Cervical cancer screening: A comparative analysis of visual inspection with acetic acid (VIA), colposcopy and histopathology in a community survey in Osun State, Nigeria
Keywords:
Cervical cancer, screening, visual inspection with acetic acid (VIA)Abstract
Background: The second target for the global strategy for eliminating cervical
cancer is impossible without mass screening of women at risk of cervical cancer
with a high-performance screening test. VIA may need to be replaced with a
low-cost high performing test that can be used for all age groups.
Objective: To determine the CCS uptake, VIA-positivity rate, and correlation
between VIA results and histology reports in VIA-positive women in Osun
State, Nigeria.
Methodology: We conducted a community-based study on 600 women
recruited from 3 communities in Osun State, Nigeria. Participants had
sensitization and then cervical screening with VIA. VIA-positive women were
triaged with colposcopy ± biopsy. Participants were treated based on
colposcopy findings. Data was analyzed with SPSS version 26. Ap-value < 0.05
was taken as statistically significant.
Results: The CCS uptake rate was 89.5% while the VIA-positivity rate was
4.9%. 10 out of 23 (43.5%) of VIA-positive women had CIN on histology.
Conclusion: The “screen-triage-treat” approach in which colposcopy was
used to triage the VIA-positive women performed better in this population.
References
Ba DM, Ssentongo P, Musa J, Agbese E, Diakite
B, Traore CB, et al. Prevalence and determinants
of cervical cancer screening in five sub-Saharan
African countries: A population-based study.
Cancer Epidemiol. 2021 Jun;72:101930. doi:
1016/j.canep.2021.101930. Epub 2021 Mar
PMID: 33756434; PMCID: PMC8864323.
Makuza JD, Nsanzimana S, Muhimpundu MA,
Pace LE, Ntaganira J, Riedel DJ. Prevalence and
risk factors for cervical cancer and pre-cancerous
lesions in Rwanda. Pan Afr Med J. 2015 Sep
;22:26. doi: 10.11604/pamj.2015.22.26.7116.
PMID: 26664527; PMCID: PMC4662515.
WHO Cervical Cancer Elimination Initiative:
from Call to Action to Global movement.
Geneva: World Health Organization 2022. Cited
o n 2 0 2 3 S e p 1 5
https://www.who.int/initiatives/cervical-cancerelimination-initiative#cms
Kabir A, Bukar M, Nggada HA, Rann HB,
Gidado A, Musa AB. Prevalence of human
papillomavirus genotypes in cervical cancer in
Res. J. Health Sci. Vol 12(2), June 2024 202
Bola-Oyabamiji et al., 2024
Maiduguri, Nigeria. Pan Afr Med J. 2019 Aug
; 3 3 : 2 8 4 . d o i :
11604/pamj.2019.33.284.18338. PMID:
; PMCID: PMC6815519.
Idowu A, Olowookere SA, Fagbemi AT,
Ogunlaja OA. Determinants of Cervical Cancer
Screening Uptake among Women in Ilorin, North
Central Nigeria: A Community-Based Study. J
Cancer Epidemiol. 2016;2016:6469240. doi:
1155/2016/6469240. Epub 2016 Jan 6.
PMID: 26880916; PMCID: PMC4736774.
Okyere J, Aboagye RG, Seidu AA, Asare BY,
Mwamba B, Ahinkorah BO. Towards a cervical
cancer-free future: women's healthcare decision
making and cervical cancer screening uptake in
sub-Saharan Africa. BMJ Open. 2022 Jul 29
;12(7):e058026. doi: 10.1136/bmjopen-2021-
PMID : 35906053 ; PMCID:
PMC9345091.
Awua AK, Wiredu EK, Afari EA, Tijani AS,
Djanmah G, Adanu RMK. A tailored withincommunity specimen collection strategy
increased uptake of cervical cancer screening in a
cross-sectional study in Ghana. BMC Public
He a lt h . 2 0 1 7 Au g 1 ; 1 8 ( 1 ): 8 0 . d o i:
1186/s12889-017-4631-y. Erratum in: BMC
Public Health. 2017 Sep 22;17 (1):736. PMID:
; PMCID: PMC5540566.
Swanson M, Ibrahim S, Blat C, Oketch S,
Olwanda E, Maloba M, et al. Evaluating a
community-based cervical cancer screening
strategy in Western Kenya: a descriptive study.
BMC Womens Health. 2018 Jul 3;18(1):116. doi:
1186/s12905-018-0586-0. PMID: 29970063;
PMCID: PMC6029075
Brisson M, Drolet M. Global elimination of
cervical cancer as a public health problem.
Lancet Oncol. 2019 Mar;20(3):319-321. doi:
1016/S1470-2045(19)30072-5. Epub 2019
Feb 19. PMID: 30795952.
Sankaranarayanan R, Esmy PO, Rajkumar R,
Muwonge R, Swaminathan R, Shanthakumari S,
et al. Effect of visual screening on cervical cancer
incidence and mortality in Tamil Nadu, India: a
cluster-randomised trial. Lancet. 2007 Aug
;370(9585):398-406. doi: 10.1016/S0140-
(07)61195-7. PMID: 17679017.
WHO guideline for screening and treatment of
cervical pre-cancer lesions for cervical cancer
prevention [Internet]. 2nd ed. Geneva: World
Health Organization; 2021. PMID: 34314129.
Cited 2023 Aug 23. Available from:
https://www.ncbi.nlm.nih.gov/books/NBK5723
/
Bhatla N, Meena J, Kumari S, Banerjee D, Singh
P, Natarajan J. Cervical Cancer Prevention
Efforts in India. Indian J Gynecol Oncol.
;19(3):41. doi: 10.1007/s40944-021-
-8. Epub 2021 Jun 2. PMID: 34095455;
PMCID: PMC8170054.
Bhatla N, Singhal S, Saraiya U, Srivastava S,
Bhalerao S, Shamsunder S, et al; (on behalf of
FOGSI Expert group). Screening and
management of preinvasive lesions of the cervix:
Good clinical practice recommendations from
the Federation of Obstetrics and Gynaecologic
Societies of India (FOGSI). J Obstet Gynaecol
Re s. 2 0 2 0 Fe b ; 4 6 ( 2 ): 2 0 1 - 2 1 4 . d o i:
1111/jog.14168. Epub 2019 Dec 9. PMID:
Shrestha AD, Neupane D, Ghimire S, Campbell
C, Kallestrup P. Community-based intervention
for cervical cancer screening uptake in a semiurban area of Pokhara Metropolitan, Nepal
(COBIN-C): study protocol for a clusterrandomized controlled trial. Trials. 2021 Jan
;22(1):94. doi: 10.1186/s13063-021-05049-3.
PMID: 33499911; PMCID: PMC7836185.
Grohar D, Vassilakos P, Benkortbi K, Tincho E,
Kenfack B, Petignat P. Scaling up communitybased cervical cancer screening in Cameroon
employing a single visit approach. Int J Gynecol
Cancer. 2020 Sep;30(9):1455-1457. doi:
1136/ijgc-2020-001422. Epub 2020 May 4.
PMID: 32371423.
Lugada E, Millar D, Haskew J, Grabowsky M,
Garg N, Vestergaard M, et al. Rapid
implementation of an integrated large-scale HIV
counseling and testing, malaria, and diarrhea
prevention campaign in rural Kenya. PLoS One.
0 1 0 A u g 2 6 ; 5 ( 8 ) : e 1 2 4 3 5 . d o i :
1371/journal.pone.0012435. Erratum in:
P L o S O n e . 2 0 1 0 ; 5 ( 9 ) . d o i :
1371/annotation/cd255375-7cf9-4b56-a81fec57e360c472. Kahn, James [corrected to Khan,
James G]. Erratum in: PLoS One. 2011;6(6).
doi:10.1371/annotation/b3e1590a-5814-4848-
e-2af40d318936. Khan, James G [corrected
to Kahn, James G]. PMID: 20865049; PMCID:
PMC2928737.
Arshad A, Salam RA, Lassi ZS, Das JK, Naqvi I,
Bhutta ZA. Community-based interventions for
the prevention and control of tuberculosis. Infect
Dis Poverty. 2014 Aug 1;3:27. doi:
1186/2049-9957-3-27. PMID: 25136445;
PMCID: PMC4136404.
Kahn JG, Muraguri N, Harris B, Lugada E,
Clasen T, Grabowsky M, et al. Integrated HIV
testing, malaria, and diarrhea prevention
campaign in Kenya: modeled health impact and
c o s t - e f f e c t i v e n e s s . P L o S O n e .
0 1 2 ; 7 ( 2 ) : e 3 1 3 1 6 . d o i :
1371/journal.pone.0031316. Epub 2012 Feb
PMID: 22347462; PMCID: PMC3275624.
Srinivas V, Herbst De Cortina S, Nishimura H,
Krupp K, Jayakrishna P, et al. Community-based
Mobile Cervical Cancer Screening Program in
Rural India: Successes and Challenges for
Implementation. Asian Pac J Cancer Prev. 2021
M a y 1 ; 2 2 ( 5 ) : 1 3 9 3 - 1 4 0 0 . d o i :
31557/APJCP.2021.22.5.1393. PMID:
; PMCID: PMC8408397.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Research Journal of Health Sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Research Journal of Health Sciences journal is a peer reviewed, Open Access journal. The Journal subscribed to terms and conditions of Open Access publication. Articles are distributed under the terms of Creative Commons License (CC BY-NC-ND 4.0). (http://creativecommons.org/licences/by-nc-nd/4.0). All articles are made freely accessible for everyone to read, download, copy and distribute as long as appropriate credit is given and the new creations are licensed under the identical terms.
